Pfizer exec moves to Merck KGaA to head fertility in USA

1 August 2018

Cheryl Schwartz has brought her time with drug giant Pfizer (NYSE: PFE) to an end by becoming a vice president with German drugmaker Merck KGaA (MRK: DE), where she will head up US fertility and endocrinology.

Ms Schwartz has been with Pfizer since 2004 and was most recently general manager of its US biosimilars business. Her previous roles with the company have included leading the global commercialization of Prevnar 13.

Germany’s Merck, which in the USA goes by the name EMD Serono, is one of the world’s leading companies in the fertility space.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK